Skip to Content
Merck
CN

15236

N,O-Bis(trimethylsilyl)carbamate

≥98.0% (T)

Synonym(s):

BSC, Trimethylsilyl N-(trimethylsilyl)carbamate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
(CH3)3SiNHCO2Si(CH3)3
CAS Number:
35342-88-2
Molecular Weight:
205.40
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
329750791
EC Number:
252-520-4
Beilstein/REAXYS Number:
2043399
MDL number:
MFCD00040476
Assay:
≥98.0% (T)
Form:
solid

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

N,O-Bis(trimethylsilyl)carbamate, ≥98.0% (T)

InChI key

DGIJAZGPLFOQJE-UHFFFAOYSA-N

InChI

1S/C7H19NO2Si2/c1-11(2,3)8-7(9)10-12(4,5)6/h1-6H3,(H,8,9)

SMILES string

C[Si](C)(C)NC(=O)O[Si](C)(C)C

assay

≥98.0% (T)

form

solid

mp

77-83 °C

functional group

amine

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Other Notes

Extremely suitable reagent for the silylation of alcohols, phenols and carboxylic acids. The only by-products are CO2 and NH3; Silyloxycarbonylation of amines; Acylisocyanates from carboxylic acid chlorides

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
048627/1V
048627/1

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

V.P. Kozyukov et al.
Zhur. Obshch. Khim., 51, 239-239 (1981)
Abi Vijenthira et al.
Blood, 136(25), 2881-2892 (2020-10-29)
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been aggregated. The objective of this study was to perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for these patients. We
Filippo Pelizzaro et al.
Cancers, 13(4) (2021-03-07)
We aimed at assessing the impact of surveillance on long-term survival in HCC patients. From the ITA.LI.CA database, we selected 1028 cases with long (≥5 years, LS group) and 2721 controls with short-term survival (<5 years, SS group). The association
Barbara Melosky et al.
The oncologist, 25(1), 64-77 (2019-05-30)
Lung cancer is one of the most common types of cancer, resulting in approximately 1.8 million deaths worldwide. Immunotherapy using checkpoint inhibitors has become standard of care in advanced non-small cell lung cancer (NSCLC), and there is increasing interest in
Yavuz Emre Arslan et al.
Biotechnology progress, 35(4), e2814-e2814 (2019-04-10)
In this study, we aimed at generating 3-dimensional (3D) decellularized bovine spinal cord extracellular matrix-based scaffolds (3D-dCBS) for neural tissue engineering applications. Within this scope, bovine spinal cord tissue pieces were homogenized in 0.1 M NaOH and this viscous mixture
View All Related Papers

Articles

Silylation of Non-Steroidal Anti-Inflammatory Drugs

Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service